Evidence map›Paper›PMID 26319230›Full record

ArticleBMC medical genetics2015

The importance of distinguishing between the odds ratio and the incidence rate ratio in GWAS.

Berit Lindum Waltoft, Carsten Bøcker Pedersen, Mette Nyegaard, Asger Hobolth

Open access · goldAbstract read
In one paragraph

Article in BMC medical genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Berit Lindum WaltoftNational Center for Register-based Research, Department of Economics and Business Economics, Aarhus University, Fuglesangs allé 4 room K10, 8210, Aarhus V, Denmark. berit@econ.au.dk.
Carsten Bøcker PedersenNational Center for Register-based Research, Department of Economics and Business Economics, Aarhus University, Fuglesangs allé 4 room K10, 8210, Aarhus V, Denmark. cbp@econ.au.dk.
Mette NyegaardThe Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark. nyegaard@biomed.au.dk.
Asger HobolthBioinformatics Research Center, Aarhus University, C.F. Møllers Allé 8, 8000, Aarhus C, Denmark. asger@birc.au.dk.
Aarhus University · DKLundbeck Foundation · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn recent years, genome wide association studies have identified many genetic variants that are consistently associated with common complex diseases, but the amount of heritability explained by these risk alleles is still low. Part of the missing heritability may be due to genetic heterogeneity and small sample sizes, but non-optimal study designs in many genome wide association studies may also have contributed to the failure of identifying gene variants causing a predisposition to disease. The normally used odds ratio from a classical case-control study measures the association between genotype and being diseased. In comparison, under incidence density sampling, the incidence rate ratio measures the association between genotype and becoming diseased. We estimate the differences between the odds ratio and the incidence rate ratio under the presence of events precluding the disease of interest. Such events may arise due to pleiotropy and are known as competing events. In addition, we investigate how these differences impact the association test.

methodsWe simulate life spans of individuals whose gene variants are subject to competing events. To estimate the association between genotype and disease, we applied classical case-control studies and incidence density sampling.

resultsWe find significant numerical differences between the odds ratio and the incidence rate ratio when the fact that gene variant may be associated with competing events, e.g. lifetime, is ignored. The only scenario showing little or no difference is an association with a rare disease and no other present associations. Furthermore, we find that p-values for association tests differed between the two study designs.

conclusionsIf the interest is on the aetiology of the disease, a design based on incidence density sampling provides the preferred interpretation of the estimate. Under a classical case-control design and in the presence of competing events, the change in p-values in the association test may lead to false positive findings and, more importantly, false negative findings. The ranking of the SNPs according to p-values may differ between the two study designs.

Indexed as

Case-Control StudiesEpidemiologic Research DesignIncidenceOdds RatioComputer SimulationGenome-Wide Association StudyLogistic Models

Identifiers

PMID26319230
PMCPMC4593225
OpenAlexW2162604147

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.